Skip to main content
. 2024 Jan 18;26:13. doi: 10.1186/s13058-024-01768-y

Fig. 5.

Fig. 5

Survival analysis based on CTC and plasma cfDNA concentration in HR+/HER2− mBC. Kaplan–Meier analysis grouped by c-MET+ CTC (A, B) or EpCAM+ CTC (C, D) and cfDNA concentration. Patients with HR+/HER2− mBC were grouped into four (A, C) or two categories (B, D)